TLANDO 112.5 MG CAPSULE

testosterone undecanoate
$6.8232per EA
Discontinued
DEA Schedule CIII

Strength

112.5 mg/1

NDC

54436011220

Classification

Brand

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Last Updated

12/23/2024

Active Ingredients

TESTOSTERONE UNDECANOATE

Approval Type

New Drug (NDA)

FDA Application

NDA208088

On Market Since

4/15/2022

Pharmacological Classes

Androgen Receptor Agonists
Androgen
Androstanes

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+15.1%